BELLERI, Mirella
 Distribuzione geografica
Continente #
NA - Nord America 3.813
EU - Europa 2.418
AS - Asia 1.014
SA - Sud America 9
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 7.260
Nazione #
US - Stati Uniti d'America 3.805
PL - Polonia 1.054
CN - Cina 492
UA - Ucraina 405
DE - Germania 317
SG - Singapore 180
IT - Italia 173
FI - Finlandia 131
HK - Hong Kong 131
GB - Regno Unito 108
IE - Irlanda 68
TR - Turchia 66
VN - Vietnam 64
IN - India 40
ES - Italia 39
FR - Francia 39
RU - Federazione Russa 26
CZ - Repubblica Ceca 21
ID - Indonesia 16
SE - Svezia 16
CA - Canada 8
BE - Belgio 7
IR - Iran 7
PH - Filippine 5
CL - Cile 4
JP - Giappone 3
AR - Argentina 2
AU - Australia 2
BD - Bangladesh 2
EU - Europa 2
HR - Croazia 2
KR - Corea 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BR - Brasile 1
CH - Svizzera 1
CO - Colombia 1
DK - Danimarca 1
GR - Grecia 1
HU - Ungheria 1
IQ - Iraq 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 7.260
Città #
Warsaw 1.054
Fairfield 580
Woodbridge 383
Ashburn 329
Jacksonville 301
Houston 291
Ann Arbor 251
Cambridge 234
Chandler 220
Seattle 199
Wilmington 183
Singapore 148
Hong Kong 130
Princeton 127
Nanjing 105
Beijing 94
Brescia 89
Helsinki 75
Dublin 68
Dearborn 63
New York 62
Istanbul 61
Dong Ket 60
Madrid 38
Des Moines 32
Nanchang 32
Shanghai 29
Hebei 26
Jinan 26
Lancaster 26
San Diego 26
Shenyang 23
Changsha 22
Los Angeles 22
Munich 22
Boardman 19
Milan 19
Brno 16
Jakarta 16
London 15
Washington 15
Jiaxing 14
San Mateo 13
Tianjin 13
Lanzhou 11
Ningbo 11
San Francisco 11
Kunming 9
Haikou 8
Hangzhou 8
Toronto 8
Brussels 7
Phoenix 7
Redwood City 7
Zhengzhou 7
Ardabil 6
Guangzhou 6
Modena 6
Verona 6
Chicago 5
Fuzhou 5
Gunzenhausen 5
Napoli 5
Nürnberg 5
Augusta 4
Ivry-sur-seine 4
Lozio 4
Norwalk 4
Olomouc 4
Santa Clara 4
Taiyuan 4
Angeles City 3
Boston 3
Changchun 3
Chiswick 3
Falls Church 3
Kilburn 3
New Delhi 3
Orange 3
Romola 3
Taizhou 3
Tokyo 3
Amsterdam 2
Buenos Aires 2
Hefei 2
Ho Chi Minh City 2
Kocaeli 2
Leawood 2
Lille 2
Monmouth Junction 2
Pune 2
Rome 2
Seoul 2
Stockholm 2
Sydney 2
Wuhan 2
Zagreb 2
Alzano Lombardo 1
Athens 1
Baku 1
Totale 5.808
Nome #
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 270
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 238
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 234
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 233
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 225
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 224
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 219
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 216
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 203
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 164
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 153
Anti-angiogenic activity of the purine analog 6-thioguanine. 150
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 147
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 142
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 141
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 139
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 132
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 131
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 125
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 124
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 122
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 120
Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. 118
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 117
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 115
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 115
Beta-Galactosylceramidase deficiency: neurovascular implications 113
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 111
Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. 108
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 106
Non competitive, chemokine-mediated inhibition of basic fibroblast growth factor-induced endothelial cell proliferation 102
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy 100
Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist 97
In vitro and ex vivo retina angiogenesis assays 96
Undersulfated and glycol-split heparins endowed with antiangiogenic activity 93
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 91
Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors. 89
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 88
Role of inflammation in FGF2-driven angiogenesis 87
The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo 87
Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice 86
Quantification of 3D Brain Microangioarchitectures in an Animal Model of Krabbe Disease 86
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 84
Endothelial cell dysfunction in globoid cell leukodystrophy 83
Angiogenic phenotype induced by basic fibroblast growth factor transfection in brain microvascular endothelial cells: an in vitro autocrine model of angiogenesis in brain tumors 79
Krabbe Disease and zebrafish: key-role of galactocerebrosidase in CNS development 78
The zebrafish knockdown of galactocerebrosidase contributes to understand the human Krabbe Disease 77
Anti-angiogenic activity of the urokinase receptor-derived peptide UPARANT 77
Substrate-immobilized HIV-1 Tat drives VEGFR2/αvβ3 integrin complex formation and polarization in endothelial cells 72
Stromal expression of long Pentraxin-3 impairs tumor growth and metastasis 72
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases 70
A novel ex vivo murine retina angiogenesis (EMRA) assay 70
Gene expression analysis identifies two distinct molecular clusters of idiopatic epiretinal membranes 70
Endothelial cells overexpressing basic fibroblast growth factor (FGF-2) induce vascular tumors in immunodeficient mice. 68
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. 67
Globoid cell leukodystrophy: inhibition of angiogenesis by beta-galactosylceramidase deficiency 61
Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma 61
Inhibition of angiogenesis in Krabbe's disease: endothelial cytoskeleton disassembly by the glycosphingolipid psychosine 59
The Urokinase Receptor-Derived Peptide UPARANT Inhibits Pathological Retinal Angiogenesis 58
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 53
Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process 52
In Vitro and In Vivo Efficacy on Retinal Neo-Vascularization of an Innovative Broad-Range Anti-Angiogenic Synthetic Peptide (Uparant) 52
Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion 51
β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism 43
Integrin -dependent antiangiogenic activity of resveratrol stereoisomers 41
Oncosuppressive and oncogenic activity of the sphingolipid-metabolizing enzyme β-galactosylceramidase 28
β-Galactosylceramidase Deficiency Causes Upregulation of Long Pentraxin-3 in the Central Nervous System of Krabbe Patients and Twitcher Mice 19
Vitreous from idiopathic epiretinal membrane patients induces glial-to-mesenchymal transition in Müller cells 13
Impact of an irreversible β-galactosylceramidase inhibitor on the lipid profile of zebrafish embryos 11
The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma Cells 10
β-Galactosylceramidase in cancer: more than a psychosine scavenger 10
Totale 7.446
Categoria #
all - tutte 32.157
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.157


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.403 0 0 0 0 136 239 230 209 160 223 102 104
2020/20211.291 45 128 73 129 108 124 39 148 146 113 123 115
2021/2022621 26 134 15 15 12 25 36 30 26 105 53 144
2022/2023554 88 31 26 44 50 135 6 49 70 4 24 27
2023/2024719 47 41 106 26 42 107 33 21 136 34 19 107
2024/2025343 18 11 5 193 116 0 0 0 0 0 0 0
Totale 7.446